» Articles » PMID: 22381268

Symptomatic Rathke Cleft Cyst: Clinical Features and Surgical Outcomes

Overview
Journal World Neurosurg
Publisher Elsevier
Date 2012 Mar 3
PMID 22381268
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To depict the clinical, operative, and histological features of Rathke cleft cysts (RCCs) in consideration of therapeutic results and recurrence rates.

Methods: This study included 40 patients (29 female; mean age, 41 years) of symptomatic RCCs with pathological verification. The mean length of follow-up was 76 months. The patients were treated by complete cyst evacuation combined with partial wall excision (7 via craniotomy and 33 transsphenoidally). All subjects were examined neurologically, radiologically, and biochemically to ascertain the clinical significance of surgery on endocrine and visual improvement.

Results: Cysts varied in size from 18 to 43 mm (mean, 19.3 mm); 38 (95.0%) had a suprasellar component. Presenting symptoms included headache (75.0%), chiasmopathy (45.0%), and endocrine dysfunction (37.5%). On magnetic resonance imaging, the signal intensities of the cysts were quite variable, with most commonly hyperintensity (75.0%) on T2-weighted and hypointensity (40.0%) on T1-weighted scans, respectively. Cyst contents were found to be mostly mucoid (52.5%) and watery (30.0%). Squamous epithelium was identified in 18 specimens (45.0%). Headaches and visual symptoms resolved or improved in 76.7% and 78.6% of patients, respectively. Hypothyroidism, hypogonadism, growth hormone deficiency, and hypocortisolemia was resolved in 44.4%, 30.0%, 33.3%, and 56.3% of patients, respectively. Two patients (5%) had repeat surgery for symptomatic relapse. Cerebrospinal fluid leakage (2.5%), new hormone deficit (7.5%), and diabetes insipidus (5.0%) were observed after surgery.

Conclusions: When RCCs are recognized intraoperatively, the evacuation of their contents and partial cyst obliteration generally afford dramatic improvements in a patient's clinical signs and symptoms, along with low complications and rate of recurrence.

Citing Articles

Rathke cleft cyst with squamous metaplasia and activating mutations of mitogen-activated protein kinase signaling: illustrative case.

Halaoui A, Estrella M, Yan C, Goodwill V, Beaumont T J Neurosurg Case Lessons. 2025; 9(3.

PMID: 39832308 PMC: 11744688. DOI: 10.3171/CASE24657.


Widening the infantile hypotonia with psychomotor retardation and characteristic Facies-1 Syndrome's clinical and molecular spectrum through NALCN structural analysis.

Vecchio D, Macchiaiolo M, Gonfiantini M, Panfili F, Petrizzelli F, Liorni N Front Genet. 2024; 15:1477940.

PMID: 39722796 PMC: 11668739. DOI: 10.3389/fgene.2024.1477940.


Comparison of clinical and radiological characteristics of inflammatory and non-inflammatory Rathke cleft cysts.

Matsushita S, Shimono T, Maeda H, Tsukamoto T, Horiuchi D, Oura T Jpn J Radiol. 2024; 43(1):32-42.

PMID: 39162782 PMC: 11717806. DOI: 10.1007/s11604-024-01641-0.


Endonasal endoscopic or endoscopic-assisted transcranial surgery of Rathke's cleft cysts: does the approach and surgical technique influence the radicality and recurrence rate?.

Linsler S, Schon L, Fischer G, Senger S, Oertel J Neurosurg Rev. 2024; 47(1):403.

PMID: 39102078 PMC: 11300485. DOI: 10.1007/s10143-024-02545-3.


Natural history and surgical outcomes of Rathke's cleft cysts: a Spanish multicenter study.

Menendez-Torre E, Gutierrez-Hurtado A, Ollero M, Irigaray A, Martin P, Parra P Front Endocrinol (Lausanne). 2024; 15:1413810.

PMID: 38952395 PMC: 11215184. DOI: 10.3389/fendo.2024.1413810.